Vimarsana
Biggest News Aggregation in the World

Medical Microinstruments News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Medical Microinstruments. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Medical Microinstruments Today - Breaking & Trending Today

Plastic Surgery Instruments Market to Grow at 9.1% CAGR, Reaching USD 3.6 Billion by 2033 - Vimarsana News

Plastic Surgery Instruments Market to Grow at 9.1% CAGR, Reaching USD 3.6 Billion by 2033

The global plastic surgery instruments market is projected to grow significantly, with the market size expected to increase from USD 1.5 billion in 2023 to approximately USD 3.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of 9.1% during the forecast period from 2024 to 2033. This robust growth i...

MMI Completes First Symani Microsurgeries In The US Following FDA Authorization Robotics & Automation News - Vimarsana News

MMI Completes First Symani Microsurgeries In The US Following FDA Authorization Robotics & Automation News

Medical Microinstruments , a robotic surgery company, has completed its first clinical cases in the United States using the Symani Surgical System.

Source: menafn.com
InnovationRx: $90 Million To Make Drugs In Space - Vimarsana News

InnovationRx: $90 Million To Make Drugs In Space

Plus: This year’s 30 Under 30 Europe list for science and healthcare

Source: forbes.com
InnovationRx: Exploring The Future Of Healthcare AI - Vimarsana News

InnovationRx: Exploring The Future Of Healthcare AI

InnovationRx is your weekly digest of healthcare news. Sign up!

Source: forbes.com
MMI Raises 110 Million in Series C Financing - Vimarsana News

MMI Raises 110 Million in Series C Financing

MMI Medical Microinstruments Inc. a robotics company dedicated to increasing treatment options and improving clinical outcomes for patients with complex conditions today announced that it has raised 110 million in Series C financing.